{"name": "Syntaxin",
 "permalink": "syntaxin",
 "crunchbase_url": "http://www.crunchbase.com/company/syntaxin",
 "homepage_url": "http://www.syntaxin.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@syntaxin.com",
 "phone_number": "44-(0)-1235-552100",
 "description": "",
 "created_at": "Fri Mar 12 03:33:05 UTC 2010",
 "updated_at": "Thu Dec 06 02:24:57 UTC 2012",
 "overview": "\u003Cp\u003ESyntaxin is a biopharmaceutical company that engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases. The biopharmaceutical company\u0026#8217;s proprietary technology platform enables the engineering of bacterial proteins by domain substitution, to produce novel cell-specific biotherapeutics that inhibit cell secretion. These products can have therapeutic effects in a wide range of indications.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       64],
      "assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],
     [[182,
       78],
      "assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],
     [[182,
       78],
      "assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$71.4M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.syntaxin.com/biopharma-news-article.php?id=39",
    "source_description": "Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline",
    "raised_amount": 32000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 31,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Life Sciences Partners",
         "permalink": "life-sciences-partners",
         "image":
          {"available_sizes":
            [[[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-150x150.jpg"],
             [[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-250x250.jpg"],
             [[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quest for Growth",
         "permalink": "quest-for-growth",
         "image":
          {"available_sizes":
            [[[150,
               139],
              "assets/images/resized/0004/3753/43753v1-max-150x150.png"],
             [[200,
               186],
              "assets/images/resized/0004/3753/43753v1-max-250x250.png"],
             [[200,
               186],
              "assets/images/resized/0004/3753/43753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 10390000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 11,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/vcs-inject-29m-syntaxin-115m-ceregene/2010-11-11?utm_medium=rss\u0026utm_source=rss",
    "source_description": "VCs inject $29M into Syntaxin, $11.5M into Ceregene",
    "raised_amount": 29000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Lundbeckfond Ventures",
         "permalink": "lundbeckfond-ventures",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0022/5191/225191v1-max-150x150.jpg"],
             [[250,
               48],
              "assets/images/resized/0022/5191/225191v1-max-250x250.jpg"],
             [[329,
               64],
              "assets/images/resized/0022/5191/225191v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Ipsen",
         "permalink": "ipsen",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0005/9640/59640v1-max-150x150.png"],
             [[195,
               63],
              "assets/images/resized/0005/9640/59640v1-max-250x250.png"],
             [[195,
               63],
              "assets/images/resized/0005/9640/59640v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LSP BioVentures",
         "permalink": "lsp-bioventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Seventure Partners",
         "permalink": "seventure-partners",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0022/4088/224088v2-max-150x150.png"],
             [[226,
               83],
              "assets/images/resized/0022/4088/224088v2-max-250x250.png"],
             [[226,
               83],
              "assets/images/resized/0022/4088/224088v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Units 4-10, The Quadrant",
    "address2": "Barton Lane",
    "zip_code": "OX14 3YS",
    "city": "Abingdon",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        107],
       "assets/images/resized/0008/0048/80048v1-max-150x150.jpg"],
      [[250,
        179],
       "assets/images/resized/0008/0048/80048v1-max-250x250.jpg"],
      [[450,
        323],
       "assets/images/resized/0008/0048/80048v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}